Table 2. SANS Total Score by Treatment and Week.
| Galantamine | Oxytocin | Placebo | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Week | N | Mean | S.D. | N | Mean | S.D. | N | Mean | S.D. |
| 0 | 19 | 36.63 | 10.97 | 15 | 33.23 | 6.91 | 19 | 36.63 | 10.61 |
| 2 | 19 | 35.22 | 10.26 | 15 | 30.07 | 6.93 | 19 | 35.05 | 10.52 |
| 4 | 18 | 34.06 | 10.64 | 15 | 31.27 | 7.53 | 18 | 34.22 | 9.61 |
| 6 | 18 | 33.22 | 11.27 | 15 | 31.40 | 6.85 | 17 | 33.47 | 8.47 |
| Δ2* | 19 | -1.41 | 3.32 | 15 | -3.17 | 4.20 | 19 | -1.58 | 4.84 |
| Δ4* | 18 | -1.69 | 3.46 | 15 | -1.97 | 4.48 | 18 | -1.47 | 5.64 |
| Δ6* | 18 | -2.53 | 4.34 | 15 | -1.83 | 3.74 | 17 | -1.00 | 4.41 |
Δx= change from week 0 at week x.
- Oxytocin versus placebo: estimated mean difference in total scores ± s.e.: -1.02 ± 1.55; t= -0.66; df=46.9; p=0.51; Cohen's d = -0.10.
- Galantamine versus placebo: estimated mean difference in total scores ± s.e.: -1.45 ± 1.39; t= -1.04; df= 46.9; p=0.30; Cohen's d= -0.15.